PharMolix
PharMolix applies multimodal AI to accelerate drug discovery and development by turning diverse biomedical data into actionable insights. The company provides a SaaS platform built around multi-modal large models and intelligent agents, including BioMedGPT (open-source), PharMolixFM (full-atom foundation model), and the commercial ChatDDFM/ChatDD assistants for conversational R&D workflows. Core technologies include large language models, multi-modal models, knowledge graphs (about 80 million entities and 100 million relationships), and bioinformatics modeling. Its tools support pharmaceutical use cases such as target identification, molecule design, business intelligence, and clinical trial insights. PharMolix targets biopharmaceutical companies and positions its platform to scale across drug discovery and development pipelines.
PharMolix
PharMolix applies multimodal AI to accelerate drug discovery and development by turning diverse biomedical data into actionable insights. The company provides a SaaS platform built around multi-modal large models and intelligent agents, including BioMedGPT (open-source), PharMolixFM (full-atom foundation model), and the commercial ChatDDFM/ChatDD assistants for conversational R&D workflows. Core technologies include large language models, multi-modal models, knowledge graphs (about 80 million entities and 100 million relationships), and bioinformatics modeling. Its tools support pharmaceutical use cases such as target identification, molecule design, business intelligence, and clinical trial insights. PharMolix targets biopharmaceutical companies and positions its platform to scale across drug discovery and development pipelines.